tradingkey.logo
tradingkey.logo
Search

Oramed Pharmaceuticals Inc

ORMP
Add to Watchlist
4.300USD
0.0000.00%
Close 08-07 16:00ETQuotes delayed by 15 min
175.98MMarket Cap
1.61P/E TTM

ORMP Income Statement

You can find the annual or quarterly income statement of Oramed Pharmaceuticals Inc here for insights into the performance and operational efficiency of Oramed Pharmaceuticals Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
FY2018Q4
FY2018Q3
FY2018Q2
FY2018Q1
FY2017Q4
FY2017Q3
FY2017Q2
FY2017Q1
FY2016Q4
FY2016Q3
FY2016Q2
FY2016Q1
FY2015Q4
FY2015Q3
FY2015Q2
FY2015Q1
FY2014Q4
FY2014Q3
FY2014Q2
FY2014Q1
FY2013Q4
FY2013Q3
FY2013Q2
FY2013Q1
FY2012Q4
FY2012Q3
FY2012Q2
FY2012Q1
Total revenue
-100.00%0.00
--0.00
--0.00
--0.00
--2.00M
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
0.00%674.00K
0.00%666.00K
-0.29%681.00K
0.15%682.00K
1.35%674.00K
-1.19%666.00K
0.29%683.00K
0.00%681.00K
-1.34%665.00K
0.00%674.00K
0.00%681.00K
-0.15%681.00K
1.20%674.00K
0.00%674.00K
10.37%681.00K
10.53%682.00K
10.26%666.00K
10.31%674.00K
-0.16%617.00K
0.00%617.00K
-1.15%604.00K
0.16%611.00K
75.07%618.00K
278.53%617.00K
388.80%611.00K
--610.00K
--353.00K
--163.00K
--125.00K
----
----
----
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Revenue
-100.00%0.00
--0.00
--0.00
--0.00
--2.00M
--0.00
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
----
0.00%674.00K
0.00%666.00K
-0.29%681.00K
0.15%682.00K
1.35%674.00K
-1.19%666.00K
0.29%683.00K
0.00%681.00K
-1.34%665.00K
0.00%674.00K
0.00%681.00K
-0.15%681.00K
1.20%674.00K
0.00%674.00K
10.37%681.00K
10.53%682.00K
10.26%666.00K
10.31%674.00K
-0.16%617.00K
0.00%617.00K
-1.15%604.00K
0.16%611.00K
75.07%618.00K
278.53%617.00K
388.80%611.00K
--610.00K
--353.00K
--163.00K
--125.00K
----
----
----
----
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Cost of revenue
-100.00%0.00
--0.00
--0.00
--0.00
--1.99M
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
--0.00
100.00%0.00
--55.00K
--35.00K
--0.00
---86.00K
--0.00
-100.00%0.00
-100.00%0.00
----
--0.00
--187.00K
--490.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating expenses
-43.71%3.66M
57.77%5.67M
-21.43%2.43M
-20.61%2.49M
119.45%6.50M
-7.27%3.59M
6.77%3.09M
-29.79%3.13M
-49.57%2.96M
-62.80%3.88M
-67.39%2.89M
-63.07%4.46M
-50.71%5.87M
28.77%10.42M
30.48%8.87M
118.53%12.09M
83.33%11.92M
118.85%8.09M
130.08%6.80M
17.45%5.53M
109.51%6.50M
22.21%3.70M
-37.92%2.96M
11.27%4.71M
-41.61%3.10M
-19.67%3.03M
-7.59%4.76M
13.97%4.23M
58.96%5.31M
8.53%3.77M
85.82%5.15M
-6.56%3.71M
11.14%3.34M
-10.82%3.47M
21.95%2.77M
95.19%3.98M
22.83%3.01M
79.11%3.89M
39.11%2.27M
21.68%2.04M
28.76%2.45M
31.78%2.17M
-14.15%1.63M
41.20%1.67M
62.81%1.90M
68.68%1.65M
42.60%1.90M
-5.89%1.19M
59.63%1.17M
4.30%977.58K
146.97%1.33M
33.97%1.26M
57.07%731.84K
--937.32K
--540.42K
--940.35K
--465.92K
R&D expenses
-27.74%1.59M
36.07%1.99M
-48.57%1.15M
-28.29%1.03M
87.11%2.21M
-17.27%1.46M
134.27%2.24M
-20.81%1.44M
-73.37%1.18M
-75.73%1.77M
-82.10%957.00K
-80.16%1.82M
-24.14%4.43M
24.52%7.28M
-2.82%5.35M
137.24%9.18M
1.07%5.84M
96.90%5.84M
185.82%5.50M
16.54%3.87M
185.56%5.77M
34.91%2.97M
-50.14%1.93M
6.62%3.32M
-53.49%2.02M
-19.53%2.20M
-7.94%3.86M
14.32%3.11M
86.81%4.35M
7.81%2.73M
85.00%4.19M
-12.83%2.72M
-1.10%2.33M
-8.88%2.54M
31.96%2.27M
139.10%3.13M
23.78%2.35M
94.89%2.78M
87.76%1.72M
15.05%1.31M
46.01%1.90M
86.95%1.43M
-16.00%915.00K
68.71%1.14M
73.48%1.30M
159.34%763.86K
30.36%1.09M
-10.10%673.33K
91.15%750.51K
-45.09%294.54K
234.59%835.64K
5.40%749.00K
113.37%392.63K
--536.43K
--249.75K
--710.65K
--184.02K
Depreciation, depletion, and amortization
0.00%30.00K
-3.23%30.00K
-40.38%31.00K
-44.44%30.00K
-46.43%30.00K
-41.51%31.00K
-3.70%52.00K
3.85%54.00K
51.35%56.00K
211.76%53.00K
260.00%54.00K
246.67%52.00K
236.36%37.00K
-10.53%17.00K
-46.43%15.00K
-46.43%15.00K
450.00%11.00K
850.00%19.00K
833.33%28.00K
1300.00%28.00K
--2.00K
-50.00%2.00K
--3.00K
0.00%2.00K
-100.00%0.00
100.00%4.00K
-100.00%0.00
0.00%2.00K
100.00%2.00K
100.00%2.00K
-50.00%1.00K
100.00%2.00K
0.00%1.00K
0.00%1.00K
100.00%2.00K
0.00%1.00K
0.00%1.00K
--1.00K
0.00%1.00K
-50.00%1.00K
0.00%1.00K
-100.00%0.00
-8.76%1.00K
79.86%2.00K
-46.55%1.00K
14.21%1.92K
37.34%1.10K
77.07%1.11K
-17.61%1.87K
--1.68K
-85.93%798.00
-88.93%628.00
-62.41%2.27K
----
--5.67K
--5.67K
--6.04K
Other operating expenses
----
---3.26M
----
----
----
----
----
----
----
--0.00
---663.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
18.69%-3.66M
-57.77%-5.67M
21.43%-2.43M
20.61%-2.49M
-51.92%-4.50M
7.27%-3.59M
-6.77%-3.09M
17.30%-3.13M
43.13%-2.96M
60.20%-3.88M
64.67%-2.89M
66.80%-3.79M
53.71%-5.21M
-31.44%-9.74M
-33.85%-8.19M
-134.53%-11.42M
-93.10%-11.25M
-145.61%-7.41M
-169.04%-6.12M
-20.58%-4.87M
-139.89%-5.83M
-28.66%-3.02M
44.24%-2.27M
-13.14%-4.04M
47.65%-2.43M
25.56%-2.34M
10.06%-4.08M
-14.69%-3.57M
-69.84%-4.64M
-10.41%-3.15M
-110.39%-4.53M
7.55%-3.11M
-13.93%-2.73M
19.38%-2.85M
-2.13%-2.15M
-75.99%-3.37M
2.08%-2.40M
-62.86%-3.54M
-29.13%-2.11M
-14.22%-1.91M
-28.76%-2.45M
-31.78%-2.17M
14.15%-1.63M
-41.20%-1.67M
-62.81%-1.90M
-68.68%-1.65M
-42.60%-1.90M
5.89%-1.19M
-59.63%-1.17M
-4.30%-977.58K
-146.97%-1.33M
-33.97%-1.26M
-57.07%-731.84K
---937.32K
---540.42K
---940.35K
---465.92K
Net non-operating interest income (expenses)
Non-operating interest income
--44.85M
--15.18M
--61.47M
7.95%15.37M
----
----
----
474.41%14.23M
218.60%5.09M
1003.07%20.12M
-58.01%435.00K
608.00%2.48M
193.57%1.60M
--1.82M
110.14%1.04M
34.62%350.00K
111.67%544.00K
----
146.50%493.00K
53.85%260.00K
22.97%257.00K
-49.37%121.00K
-23.95%200.00K
-38.10%169.00K
-26.92%209.00K
-6.27%239.00K
25.84%263.00K
25.81%273.00K
28.83%286.00K
32.12%255.00K
-0.48%209.00K
6.90%217.00K
19.35%222.00K
34.03%193.00K
53.28%210.00K
58.59%203.00K
144.74%186.00K
128.57%144.00K
168.63%137.00K
236.84%128.00K
181.48%76.00K
147.70%63.00K
-35.84%51.00K
-48.62%38.00K
-41.46%27.00K
--25.43K
-6.04%79.49K
10.71%73.96K
-36.16%46.12K
----
27545.10%84.59K
781.96%66.80K
938.88%72.24K
----
--306.00
--7.57K
--6.95K
Non-operating interest expense
----
----
----
----
332.09%2.56M
-100.00%0.00
1766.83%15.42M
--261.00K
--592.00K
259.39%2.95M
--826.00K
----
----
--820.00K
----
----
----
----
----
----
775.00%175.00K
-4.73%423.00K
-42.86%8.00K
-89.47%2.00K
150.00%20.00K
1332.26%444.00K
-51.72%14.00K
-13.64%19.00K
-61.90%8.00K
-13.89%31.00K
45.00%29.00K
4.76%22.00K
-12.50%21.00K
20.00%36.00K
-13.04%20.00K
-38.24%21.00K
41.18%24.00K
328.57%30.00K
--23.00K
3300.00%34.00K
-19.05%17.00K
395.05%7.00K
----
-68.88%1.00K
851.95%21.00K
--1.41K
-33.49%4.17K
-90.22%3.21K
-99.26%2.21K
----
-38.88%6.26K
246.20%32.84K
1429.75%299.16K
----
--10.25K
--9.49K
--19.56K
Gains from sale of securities
----
----
----
----
----
---6.19M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
88.54%-18.32K
----
--0.00
--0.00
---159.83K
--0.00
--0.00
--0.00
Special income (expenses)
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
19.63%323.00K
16.87%-202.00K
309.20%182.00K
-605.00%-303.00K
--270.00K
---243.00K
---87.00K
--60.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
112.98%18.32K
--0.00
100.00%0.00
--0.00
---141.14K
--0.00
---43.11K
--0.00
Other non-operating income (expenses)
--8.25M
--293.00K
--408.00K
--257.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
--224.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income before tax
800.48%49.44M
200.14%9.80M
421.20%59.45M
21.18%13.13M
-560.10%-7.06M
-173.58%-9.78M
-463.61%-18.51M
925.44%10.84M
142.48%1.53M
252.20%13.30M
54.09%-3.28M
88.14%-1.31M
66.28%-3.61M
-21.57%-8.74M
-27.16%-7.15M
-140.17%-11.07M
-92.24%-10.71M
-139.85%-7.19M
-146.28%-5.63M
-24.95%-4.61M
-119.03%-5.57M
-31.40%-3.00M
43.91%-2.28M
-8.44%-3.69M
40.89%-2.54M
22.08%-2.28M
6.48%-4.07M
-16.63%-3.40M
-69.97%-4.30M
-8.53%-2.93M
-121.58%-4.35M
8.39%-2.92M
-13.19%-2.53M
21.28%-2.70M
1.55%-1.96M
-75.08%-3.18M
6.44%-2.24M
-61.79%-3.42M
-26.09%-2.00M
-11.06%-1.82M
-26.05%-2.39M
-30.28%-2.12M
13.40%-1.58M
-46.84%-1.64M
-68.64%-1.90M
-63.16%-1.62M
-45.49%-1.83M
9.06%-1.11M
-17.27%-1.12M
66.20%-995.91K
-128.27%-1.26M
-24.41%-1.23M
-100.36%-958.75K
---2.95M
---550.37K
---985.38K
---478.52K
Income tax
1805.82%11.13M
-150.96%-212.00K
876.35%11.06M
-107.71%-126.00K
--584.00K
--416.00K
--1.13M
--1.63M
----
--0.00
-100.00%0.00
----
----
--0.00
--100.00K
----
----
--0.00
--0.00
--0.00
----
--0.00
--0.00
----
----
--0.00
--0.00
--300.00K
----
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
--0.00
--0.00
--400.00K
133600.00%1.33M
----
----
----
-125.00%-1.00K
----
----
--0.00
101.95%4.00K
----
--0.00
--0.00
-327.30%-205.06K
--0.00
--0.00
--0.00
--90.22K
--0.00
--0.00
--0.00
Income after tax
601.31%38.31M
198.14%10.01M
346.35%48.39M
44.07%13.26M
-598.17%-7.64M
-176.71%-10.20M
-498.11%-19.64M
800.99%9.20M
142.48%1.53M
252.20%13.30M
54.72%-3.28M
88.14%-1.31M
66.28%-3.61M
-21.57%-8.74M
-28.94%-7.25M
-140.17%-11.07M
-92.24%-10.71M
-139.85%-7.19M
-146.28%-5.63M
-24.95%-4.61M
-119.03%-5.57M
-31.40%-3.00M
43.91%-2.28M
0.35%-3.69M
40.89%-2.54M
22.08%-2.28M
6.48%-4.07M
-26.92%-3.70M
-69.97%-4.30M
-8.53%-2.93M
-121.58%-4.35M
8.39%-2.92M
3.98%-2.53M
43.36%-2.70M
1.55%-1.96M
-75.08%-3.18M
-10.29%-2.64M
-124.95%-4.76M
-26.09%-2.00M
-11.06%-1.82M
-26.05%-2.39M
-29.90%-2.12M
13.40%-1.58M
-46.84%-1.64M
-68.64%-1.90M
-105.97%-1.63M
-45.49%-1.83M
9.06%-1.11M
-17.27%-1.12M
73.96%-790.84K
-128.27%-1.26M
-24.41%-1.23M
-100.36%-958.75K
---3.04M
---550.37K
---985.38K
---478.52K
Net income from continuous operations
601.31%38.31M
198.14%10.01M
346.35%48.39M
44.07%13.26M
-598.17%-7.64M
-176.71%-10.20M
-498.11%-19.64M
800.99%9.20M
142.48%1.53M
252.20%13.30M
54.72%-3.28M
88.14%-1.31M
66.28%-3.61M
-21.57%-8.74M
-28.94%-7.25M
-140.17%-11.07M
-92.24%-10.71M
-139.85%-7.19M
-146.28%-5.63M
-24.95%-4.61M
-119.03%-5.57M
-31.40%-3.00M
43.91%-2.28M
0.35%-3.69M
40.89%-2.54M
22.08%-2.28M
6.48%-4.07M
-26.92%-3.70M
-69.97%-4.30M
-8.53%-2.93M
-121.58%-4.35M
8.39%-2.92M
3.98%-2.53M
43.36%-2.70M
1.55%-1.96M
-75.08%-3.18M
-10.29%-2.64M
-124.95%-4.76M
-26.09%-2.00M
-11.06%-1.82M
-26.05%-2.39M
-29.90%-2.12M
13.40%-1.58M
-46.84%-1.64M
-68.64%-1.90M
-105.97%-1.63M
-45.49%-1.83M
9.06%-1.11M
-17.27%-1.12M
73.96%-790.84K
-128.27%-1.26M
-24.41%-1.23M
-100.36%-958.75K
---3.04M
---550.37K
---985.38K
---478.52K
Other net gains and losses
----
---7.74M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net Income attributable to non-controlling interests
----
100.00%0.00
73.91%-6.00K
-250.00%-28.00K
100.00%0.00
75.00%-10.00K
62.90%-23.00K
93.28%-8.00K
99.07%-2.00K
79.27%-40.00K
67.88%-62.00K
77.72%-119.00K
23.67%-216.00K
42.04%-193.00K
53.83%-193.00K
---534.00K
-36.06%-283.00K
---333.00K
---418.00K
----
---208.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net income attributable to controlling interests
601.31%38.31M
198.23%10.01M
346.67%48.40M
44.25%13.29M
-597.53%-7.64M
-176.40%-10.19M
-508.91%-19.62M
871.52%9.21M
145.24%1.54M
256.10%13.34M
54.36%-3.22M
88.66%-1.19M
67.43%-3.40M
-24.66%-8.54M
-35.59%-7.06M
-128.58%-10.53M
-87.16%-10.43M
-128.74%-6.85M
-127.98%-5.21M
-24.95%-4.61M
-119.03%-5.57M
-31.40%-3.00M
43.91%-2.28M
0.35%-3.69M
40.89%-2.54M
22.08%-2.28M
6.48%-4.07M
-26.92%-3.70M
-69.97%-4.30M
-8.53%-2.93M
-121.58%-4.35M
8.39%-2.92M
3.98%-2.53M
43.36%-2.70M
1.55%-1.96M
-75.08%-3.18M
-10.29%-2.64M
-124.95%-4.76M
-26.09%-2.00M
-11.06%-1.82M
-26.05%-2.39M
-29.90%-2.12M
13.40%-1.58M
-46.84%-1.64M
-68.64%-1.90M
-105.97%-1.63M
-45.49%-1.83M
9.06%-1.11M
-17.27%-1.12M
73.96%-790.84K
-128.27%-1.26M
-24.41%-1.23M
-100.36%-958.75K
---3.04M
---550.37K
---985.38K
---478.52K
Net income attributable to common shareholders
601.31%38.31M
198.23%10.01M
346.67%48.40M
44.25%13.29M
-597.53%-7.64M
-176.40%-10.19M
-508.91%-19.62M
871.52%9.21M
145.24%1.54M
256.10%13.34M
54.36%-3.22M
88.66%-1.19M
67.43%-3.40M
-24.66%-8.54M
-35.59%-7.06M
-128.58%-10.53M
-87.16%-10.43M
-128.74%-6.85M
-127.98%-5.21M
-24.95%-4.61M
-119.03%-5.57M
-31.40%-3.00M
43.91%-2.28M
0.35%-3.69M
40.89%-2.54M
22.08%-2.28M
6.48%-4.07M
-26.92%-3.70M
-69.97%-4.30M
-8.53%-2.93M
-121.58%-4.35M
8.39%-2.92M
3.98%-2.53M
43.36%-2.70M
1.55%-1.96M
-75.08%-3.18M
-10.29%-2.64M
-124.95%-4.76M
-26.09%-2.00M
-11.06%-1.82M
-26.05%-2.39M
-29.90%-2.12M
13.40%-1.58M
-46.84%-1.64M
-68.64%-1.90M
-105.97%-1.63M
-45.49%-1.83M
9.06%-1.11M
-17.27%-1.12M
73.96%-790.84K
-128.27%-1.26M
-24.41%-1.23M
-100.36%-958.75K
---3.04M
---550.37K
---985.38K
---478.52K
Basic earnings per share
606.89%0.94
197.67%0.24
341.60%1.16
41.54%0.32
-592.85%-0.19
-176.13%-0.25
-502.21%-0.48
857.75%0.22
144.36%0.04
251.87%0.33
55.88%-0.08
89.07%-0.03
68.54%-0.08
-4.91%-0.22
-3.79%-0.18
-59.11%-0.27
-14.90%-0.27
-62.99%-0.21
-76.83%-0.17
17.56%-0.17
-61.17%-0.23
2.96%-0.13
57.82%-0.10
2.39%-0.21
40.97%-0.15
27.14%-0.13
22.22%-0.23
-5.04%-0.21
-38.71%-0.25
10.58%-0.18
-103.00%-0.30
15.78%-0.20
10.95%-0.18
44.64%-0.20
2.91%-0.15
-66.82%-0.24
3.35%-0.20
-96.54%-0.36
-4.07%-0.15
4.98%-0.14
-10.47%-0.21
-13.22%-0.18
20.91%-0.15
-23.80%-0.15
-32.05%-0.19
-55.83%-0.16
-6.28%-0.18
28.14%-0.12
-0.75%-0.14
79.44%-0.10
-85.35%-0.17
-0.88%-0.17
-71.45%-0.14
---0.51
---0.09
---0.17
---0.08
Diluted earnings per share
592.44%0.91
197.67%0.24
335.85%1.13
40.80%0.31
-601.52%-0.19
-178.02%-0.25
-502.21%-0.48
846.26%0.22
143.59%0.04
248.18%0.32
55.88%-0.08
89.07%-0.03
68.54%-0.08
-4.91%-0.22
-3.79%-0.18
-59.11%-0.27
-14.90%-0.27
-62.99%-0.21
-76.83%-0.17
17.56%-0.17
-61.17%-0.23
2.96%-0.13
57.82%-0.10
2.39%-0.21
40.97%-0.15
27.14%-0.13
22.22%-0.23
-5.04%-0.21
-38.71%-0.25
10.58%-0.18
-103.00%-0.30
15.78%-0.20
10.95%-0.18
44.64%-0.20
2.91%-0.15
-66.82%-0.24
3.35%-0.20
-96.54%-0.36
-4.07%-0.15
4.98%-0.14
-10.47%-0.21
-13.22%-0.18
20.91%-0.15
-23.80%-0.15
-32.05%-0.19
-55.83%-0.16
-6.28%-0.18
28.14%-0.12
-0.75%-0.14
53.07%-0.10
-85.35%-0.17
-0.88%-0.17
-71.45%-0.14
---0.22
---0.09
---0.17
---0.08
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read Oramed Pharmaceuticals Inc's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing ORMP stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Oramed Pharmaceuticals Inc's revenue at year end?

Oramed Pharmaceuticals Inc reported 2.00M in revenue for fiscal year 2025, up from 2.00M in the previous year.

What was Oramed Pharmaceuticals Inc's net income for the year?

Oramed Pharmaceuticals Inc posted 64.05M in net income for fiscal year 2025.

How much net income did Oramed Pharmaceuticals Inc post in the last quarter?

Oramed Pharmaceuticals Inc reported 38.31M in net income for the latest quarter。

What was Oramed Pharmaceuticals Inc's annual operating profit?

Oramed Pharmaceuticals Inc's operating income was -15.09M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.